Cochlear Ltd (ASX: COH) Share Price and News

Ms McLoughlin has experience as a director on the boards of ASX Top 50 Companies in financial services (including banking, life insurance, superannuation, asset management and general insurance), resources, health insurance and infrastructure sectors over the past 14 years. Other boards are Chairman of the Suncorp Group Limited. Co-founder and Chairman of the Minerva Network. Former directorships include Chairman and Director of Venues NSW and Chairman of Destination NSW. Director, nib Holding Limited, Whitehaven Coal Limited, Spark Infrastructure, the McGrath Foundation and more recently the Chancellor of the University of Wollongong. She is Chair of the People and Culture Committee and member of the Risk and Product and Services Innovation Committee.

Mr Daniell has over 40 years of experience in the medical device industry with executive leadership experience. He is Former Managing Director and CEO of Fisher & Paykel Healthcare Corporation Limited responsible for the global business and operations including the design, manufacture and marketing of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. Other directorships are Director of Fisher & Paykel Healthcare Corporation Ltd; Director, Tait International Limited; Director, Medical Research Commercialisation Fund. Former directorships include Advisory Board Chair, Te Titoki Mataora (NZ). He is Chair of the Product and Services Innovation Committee and member of the Risk and Medical Science Committee.

Ms Deans has experience leading technology enabled businesses across e-commerce, media and financial services. Deans was former Chief Executive Officer of netus, Hoyts Cinemas, ecorp and eBay Australia and New Zealand. Other directorships include Director of Ramsay Health Care Limited, Calix Limited, Deputy Group Pty Ltd and Fitness Passport Pty Ltd. Director of The Observership Program. Former directorships include SCEGGS Darlinghurst Limited, Westpac Banking Corporation, Insurance Australia Group Limited and Social Ventures Australia. She was former Member of AICD Corporate Governance Committee.

Ms Penrose has executive career in senior leadership and Chief Financial Officer roles in financial services. She is a company director, having served on the boards of a number of ASX100 companies and experienced across health care, financial services, property and infrastructure industries. Other boards include Director, Ramsay Health Care Limited, Bank of Queensland Limited and Reece Limited. Director, Ramsay General De Sante (associated with Karen's directorship of Ramsay Health Care Limited), Marshall Investments Pty Limited, NSW Waratahs Ltd and Waratahs Rugby Pty Ltd. Former directorships are Vicinity Centres, Estia Health Ltd, Rugby Australia Limited. She is Chair of the Risk Committee and member of the People and Culture and Product and Services Innovation Committee.

Mr Boreham Led organisations in information technology, new media and the creative industries through periods of rapid change and innovation. He is Former Managing Director of IBM Australia and New Zealand. Other boards include Strategic Advisor, IXUP. Former directorships were held with Southern Cross Media Group, Data#3 and Link Group. Chairman of Screen Australia, Advance (Global Australian Network), Business School and Industry Advisory Board for the University of Technology, Sydney and Advisory Board IXUP. he is member of the Risk Committee, People and Culture and Product and Services Innovation Committees.

Mr Robinson has over 20 years of leadership experience as an academic physician/scientist across research, healthcare and medicine, and tertiary education. He is Co-Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research and Chair of Research, North Sydney Local Health District. He is Former Dean of The University of Sydney's Sydney Medical School and Head of Medicine at Sydney's Royal North Shore Hospital. Other boards are Director, MaynePharma, QBiotics, Ecofibre and EOF BIO LLC (associated with the Ecofibre directorship). Deputy Chairman (former Chairman), Hoc Mai Foundation. Senior Advisor to McKinsey & Company and Advisor to MinterEllison. Former directorships include Chairman of National Health and Medical Research Council; chairman of Medical Benefits Schedule Review Taskforce; Director, Lorica Health Pty Limited, Firefly and Digital Health Agency CRC and Woolcock Institute of Medical Research. He is Chair of Medical Science Committee and member of the Product and Services Innovation Committees.

Mr Howitt has experience across the Company in roles including Chief Operating Officer, President, Asia Pacific and SVP, Manufacturing and Logistics. Prior to joining Cochlear he worked for Boston Consulting Group and held a General Management role at Boral. Dig is a member of the Champions of Change Coalition, STEM group. He is member of the Medical Science and Product and Services Innovation Committees.

Mr Prado has over 34 years of global experience in the medical device and pharmaceutical industries with senior executive leadership roles in Johnson & Johnson medical device businesses in the US, Asia-Pac and EMEA. He is Former Company Group Chairman of Ethicon, a surgical company. Other boards are Ambu A/S. Former directorships include Co-lead Director of Verb Surgical. Advisory Board, Singapore Management University Lee Kong Chian School of Business. He is member of the Medical Science, People and Culture and Product and Services Innovation Committee.

Ms Clarke has more than 30 years of commercial experience, including 20 years of executive roles at medical devices, medical equipment and healthcare services businesses in large global companies. Ms Clarke was most recently CEO and Executive Vice President ASEAN Pacific for Philips . Ms Clarke will become a member of the People and Culture Committee, the Product & Services Innovation Committee .

-

-

-

-

-

-